Akshat Jain: Transforming Sickle Cell Care With Practical Apheresis Frameworks
Akshat Jain, Hematology Pediatric Workforce Task Force at American Society of Hematology, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Therapeutic Apheresis and Dialysis, adding:
“Presenting out latest research in Sickle Cell Disease methodology and innovation simplifying first truly explicit, transparent, evidence-graded framework, for apheresis indications and strategies.
The paper’s importance is that it helped turn sickle cell care from fragmented expert opinion into a clearer guideline process that others can adopt or adapt.
First-time guideline implications:
For the first time, we clearly set out concrete standards for cerebrovascular care in SCD, including annual transcranial Doppler screening for children with HbSS/HbSβ0 thalassemia, transfusion-based stroke prevention in higher-income settings, hydroxyurea as an alternative in lower-resource settings, urgent transfusion for acute neurologic deficits, and MRI screening for silent cerebral infarcts.
The paper’s broader implication is that guideline development in SCD should not wait for perfect evidence; it should use the best available evidence plus structured expert judgment and patient priorities to create actionable care pathways.
Practical takeaways
The paper’s importance is that it helped turn sickle cell care from fragmented expert opinion into a clearer guideline process that others can adopt or adapt.”
Title: Red Blood Cell Exchange in Sickle Cell Disease Care: A Comprehensive Review
Authors: Mahtab Mashayekhi, Mojtaba Akhtari, Akshat Jain, Nasim Salimiaghdam, Amir Abdipour
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy